| Date |
Title |
Rating |
| 2012-02-29 |
FDA approves MedImmune's FluMist Quadrivalent vaccine |
None |
| 2012-02-29 |
LAU-0901 drug protects brain in an experimental stroke model |
None |
| 2012-02-29 |
New NOSH-aspirin appears more effective against cancer |
None |
| 2012-02-29 |
Bayer receives FDA approval for lower dose formulation of ANGELIQ |
None |
| 2012-02-29 |
Biogen Idec announces new easier to use injection for multiple sclerosis |
None |
| 2012-02-29 |
Statins to carry revised warning labels: FDA |
None |
| 2012-02-29 |
Novartis defends challenge to Indian medicines patent law |
None |
| 2012-02-29 |
Combination treatment for pancreatic cancer increases intratumoral gemcitabine levels |
None |
| 2012-02-29 |
Alzheimer's disease drugs may act like a bad electrician |
None |
| 2012-02-29 |
D-serine improves depressed rats' brain plasticity and memory |
None |
| 2012-02-29 |
Activists protest Novartis challenge to Indian patent law |
None |
| 2012-02-29 |
HPV vaccine recommended for boys |
None |
| 2012-02-29 |
Shire, arGEN-X partner to create novel antibodies against rare diseases |
None |
| 2012-02-29 |
SWHR, NAMS encourage women to understand benefits and risks of hormone therapy |
None |
| 2012-02-29 |
First study to show effects of ecstasy drug on fetal and infant development |
None |
| 2012-02-29 |
Cannabinoids may be a target for new strategies in cancer treatment |
5 |
| 2012-02-29 |
Quitting hormone therapy can lead to breast tumor regression |
None |
| 2012-02-29 |
Maturitas publishes EMAS' clinical guide on SERMs against postmenopausal osteoporosis |
None |
| 2012-02-29 |
XL888 inhibitor can prevent vemurafenib resistance in melanoma patients |
None |
| 2012-02-28 |
Silver Hill Hospital announces opening of Chronic Pain and Addiction Center |
None |
| 2012-02-28 |
Biogen Idec receives FDA approval for two separate dosing innovations to treat MS |
None |
| 2012-02-28 |
FDA grants orphan drug designation to Ultragenyx UX003 for treatment of MPS 7 |
None |
| 2012-02-28 |
Blog examines sale of fake malaria drugs in Tanzania |
None |
| 2012-02-28 |
Telephone-based counseling program does not improve osteoporosis medication adherence |
None |
| 2012-02-28 |
Report identifies patterns in misuse of illicit and prescription drugs among young adults |
None |
| 2012-02-28 |
Swaziland looking to shore up funding for AIDS treatment, testing supplies |
None |
| 2012-02-28 |
Study finds subtle cognitive deficits in women treated with CMF chemotherapy |
None |
| 2012-02-28 |
Aurora-A protein blocks proper functioning of tumor-suppressor p73 |
None |
| 2012-02-28 |
JAM study highlights emerging problem in addiction therapy |
2 |
| 2012-02-28 |
Biogen Idec, Samsung Biologics establish joint venture to develop and market biosimilars |
None |
| 2012-02-28 |
Sleeping pills may increase risk of cancer-related death |
5 |
| 2012-02-28 |
Octapharma submits octaplasLG BLA with FDA to treat TTP |
None |
| 2012-02-27 |
Chemically altered osteoporosis drug may fight malaria |
3 |
| 2012-02-27 |
USPTO issues two patents on 'Novel Shigella protein antigens and methods' to IVI |
None |
| 2012-02-27 |
FDA assigns Priority Review designation to JRD's XARELTO sNDA |
None |
| 2012-02-27 |
Glenmark Generics recalls batch of birth control pills |
None |
| 2012-02-27 |
Cross-protective vaccines will make a bout with influenza less severe |
None |
| 2012-02-27 |
Ritalin improves awareness of performance errors |
None |
| 2012-02-27 |
EMA acceptance of peginesatide MAA triggers $5M milestone payment to Affymax |
None |
| 2012-02-27 |
GSK, Angiochem to develop and commercialize LSD treatments |
None |
| 2012-02-27 |
SLU investigator aims to reduce chemotherapy-induced peripheral neuropathy |
None |
| 2012-02-27 |
New method can predict whether Tylenol-poisoning patients need liver transplant |
None |
| 2012-02-27 |
CML patients can benefit from imatinib after unsuccessful interferon therapies |
None |
| 2012-02-27 |
Survey: 49% of asthma patients are not using controllers |
None |
| 2012-02-27 |
Two-target approach may effectively stop pancreatic cancer metastasis |
None |
| 2012-02-27 |
Scripps Florida receives NIH grant to create novel HIV inhibitors |
None |
| 2012-02-27 |
Cabozantinib blocks c-MET and VEGF signaling in mouse model of pancreatic cancer |
None |
| 2012-02-27 |
Statins may reduce risk of depression in patients with heart disease |
None |
| 2012-02-26 |
Exelixis announces cabozantinib preclinical data on pancreatic cancer |
None |
| 2012-02-26 |
Cost of NHS prescriptions set to rise |
None |
| 2012-02-26 |
Skin cancer drug may prolong survival in advanced cases: Study |
None |
| 2012-02-26 |
FDA panel votes in favor of earlier rejected anti-obesity drug Qnexa |
None |
| 2012-02-24 |
Rhei granted marketing approval for MuGard in China |
None |
| 2012-02-24 |
New erectile dysfunction supplement with Bio-Energy infusion |
None |
| 2012-02-24 |
New Huntington's drug might operate via previously unknown mechanisms of action |
None |
| 2012-02-24 |
Dopamine therapy can boost creativity in patients with Parkinson's |
None |
| 2012-02-24 |
Forest Laboratories' Colobreathe dry powder inhaler receives EMA approval |
5 |
| 2012-02-24 |
Washington state law requiring pharmacies stock emergency contraception is struck down |
None |
| 2012-02-24 |
Bath salts mimic effects of two powerful narcotics |
None |
| 2012-02-24 |
EMA accepts MAA filing of Genzyme's teriflunomide for MS |
None |
| 2012-02-23 |
Can-Fite receives FDA Orphan Drug Status for CF102 to treat hepatocellular carcinoma |
None |
| 2012-02-23 |
Impax announces FDA acceptance of NDA filing for IPX066 |
None |
| 2012-02-23 |
NHS approves new rheumatoid arthritis drug RoActemra |
5 |
| 2012-02-23 |
Pfizer responds to CDC’S ACIP discussion related to use of Prevnar 13 in adults over 50 |
None |
| 2012-02-23 |
FDA, pharmaceutical companies announce solution to cancer drug shortage |
None |
| 2012-02-23 |
Intravenous ibuprofen: A key addition to perioperative pain management |
None |
| 2012-02-23 |
Scientists design compounds that act against myotonic dystrophy type 1 RNA |
5 |
| 2012-02-23 |
Burma unable to expand HIV, TB treatment programs without more donor support, MSF report says |
None |
| 2012-02-23 |
Actelion, Auxilium partner to develop and commercialize XIAFLEX |
None |
| 2012-02-23 |
FDA approves Boston Scientific's ION and TAXUS Liberte paclitaxel-eluting stents |
None |
| 2012-02-23 |
Novartis delivers 100 million child-friendly antimalarial treatments to 39 countries |
None |
| 2012-02-23 |
FDA EMDAC recommends approval of VIVUS' Qnexa for obesity |
None |
| 2012-02-23 |
Health Canada accepts Paladin's Silenor NDS for review |
None |
| 2012-02-23 |
Depomed, Santarus reach agreement to resolve GLUMETZA patent litigation with Lupin |
None |
| 2012-02-22 |
Statins can reduce risk of depression |
None |
| 2012-02-22 |
Making a medicinewise choice between brands |
4 |
| 2012-02-22 |
FDA approves new supplies of drugs that are facing shortages |
None |
| 2012-02-22 |
Counterfeit drugs on the Internet find their way into legitimate pharmacies |
None |
| 2012-02-22 |
Study aims to achieve early detection of heart disease |
None |
| 2012-02-22 |
UMMS' iHeal project uses emerging technologies to detect drug cravings and intervene |
None |
| 2012-02-22 |
FDA approves APP's preservative-free Methotrexate Injection |
None |
| 2012-02-22 |
Russian government's censorship of websites with harm reduction methods for drug users helps fuel HIV epidemic, IPS reports |
None |
| 2012-02-22 |
BioLineRx BL-7010 may reduce gluten toxicity in patients with celiac disease |
None |
| 2012-02-22 |
New chemical compound to treat brain damage from stroke |
None |
| 2012-02-22 |
Promising antibiotic alternative to fight bacteria that causes strep throat |
None |
| 2012-02-22 |
EMA grants positive scientific opinion for Pyramax to treat malaria |
None |
| 2012-02-22 |
Weight gain or loss may also depend on medicines taken |
None |
| 2012-02-21 |
FDA grants orphan-drug designation to Arno's AR-42 for treatment of meningioma, schwannoma |
2 |
| 2012-02-21 |
FDA to review rejected weight loss drug Qnexa |
None |
| 2012-02-21 |
Drug 'addicted' newborn the latest hysteria driven absurdity |
None |
| 2012-02-21 |
AWMSG makes prostate cancer drug abiraterone available on the NHS |
None |
| 2012-02-20 |
Some answers about prescription psychiatric drugs |
None |
| 2012-02-20 |
KI's chemical interaction map shows how inhibitors bind to PARP enzymes |
4 |
| 2012-02-20 |
FDA to review inhaled caffeine device - AeroShot |
None |
| 2012-02-20 |
Massive infant Tylenol recall |
None |
| 2012-02-20 |
Natural compound of Chilean avocado plant can combat resistant yellow staphylococci |
None |
| 2012-02-20 |
EC approves Plexxikon's Zelboraf to treat BRAF mutation-positive MM |
None |
| 2012-02-20 |
Modified imatinib cancer drug prevents morphine tolerance in rats |
None |
| 2012-02-19 |
Study reveals potential strength of different anti-HIV combination drugs |
None |
| 2012-02-19 |
Clazosentan drug shows promise against TBI in rats |
None |
| 2012-02-18 |
Substituting antiepileptic drugs may lead to increase in risk of epilepsy |
None |
| 2012-02-18 |
Mobius selects The Apothecary Shops as distribution partner for Mitosol Kit for Ophthalmic Use |
None |
| 2012-02-18 |
FDA to reconsider diet drug that failed to get approval in 2010 |
None |
| 2012-02-18 |
Celebrity Nutritionist endorses Pure Health's Black Raspberry supplement |
4 |
| 2012-02-18 |
More than 1 in 4 elderly patients received potentially hazardous drugs during 2007 |
None |
| 2012-02-18 |
PCMA launches That's What PBMs Do campaign in Maryland |
None |
| 2012-02-18 |
WHO confirms recommendations regarding HIV, female hormonal contraceptives after review of studies |
None |
| 2012-02-18 |
EMA CHMP recommends CTI's Pixuvri for conditional approval |
None |
| 2012-02-18 |
Study: Thrombolytic therapy can be safely used in children with stroke |
None |
| 2012-02-18 |
CHPA releases statement on new Oklahoma economic impact study |
None |
| 2012-02-18 |
Zhejiang Hisun Pharmaceutical, Pfizer sign framework agreement |
None |
| 2012-02-18 |
FSMB initiatives to raise awareness about opioid prescribing |
None |
| 2012-02-18 |
Nano-enabled intranasal formulation of teriparatide can treat osteoporosis |
5 |
| 2012-02-18 |
Corcept receives FDA approval for Korlym to treat endogenous Cushing's syndrome |
None |
| 2012-02-17 |
Atomoxetine drug may restore memory deficits in menopausal women |
None |
| 2012-02-17 |
FDA approves Medtronic's Resolute Integrity DES to treat CAD |
None |
| 2012-02-17 |
BYETTA-basal insulin combination therapy receives EMA CHMP positive opinion |
None |
| 2012-02-17 |
Bill to bar synthetic recreational drugs hits roadblock |
None |
| 2012-02-17 |
Four new drugs can extend survival and prognosis of prostate cancer |
3 |
| 2012-02-17 |
Shortage looming, drug maker agrees to release emergency supplies of kids' cancer drug |
None |
| 2012-02-17 |
Burkina Faso government urged to increase health budget as country faces ARV stock outs |
None |
| 2012-02-17 |
New preclinical data from Regulus' miR-21 study on kidney fibrosis |
None |
| 2012-02-17 |
Indian authorities vaccinate children crossing India-Pakistan border; Distrust of polio vaccines grows in Pakistan |
None |
| 2012-02-17 |
Epilepsy community concerned over AHRQ's AED drug comparison study |
4 |
| 2012-02-17 |
AstraZeneca launches ARIMIDEX Direct to help cancer patients |
None |
| 2012-02-16 |
Pfizer, Mylan enter settlement agreement to resolve e-cue patent litigation |
None |
| 2012-02-16 |
FDA grants orphan drug designation to CSL Behring's rVIIa-FP |
None |
| 2012-02-16 |
DEA tries to stem prescription drug abuse by suspending pharmacies |
None |
| 2012-02-16 |
AHF dismayed at FDA decision to expedite review for expanded use of Gilead's AIDS drug, Truvada |
None |
| 2012-02-16 |
Drugmaker warns that fake cancer drug is on the market |
None |
| 2012-02-16 |
Hospitals would have to voluntarily return overpayments under new proposal |
None |
| 2012-02-16 |
Researchers share libraries of chemical compounds to spur development of drug candidates |
None |
| 2012-02-16 |
Pure Health launches new fresh freeze dried Black Raspberry capsules |
None |
| 2012-02-16 |
ASH addresses severe shortage of methotrexate drug |
None |
| 2012-02-16 |
U.S. FDA accepts Pfizer's tafamidis NDA for treatment of TTR-FAP |
None |
| 2012-02-15 |
Valeant receives FDA approval for secondary supplier of Methoxsalen |
None |
| 2012-02-15 |
Counterfeit anti-cancer drug Avastin raises concerns |
None |
| 2012-02-15 |
FDA approves preservative-free drug for glaucoma |
None |
| 2012-02-15 |
VPCI announces successful petition to the FDA for removal from Import Alert |
None |
| 2012-02-15 |
Steady increase in Low Molecular Weight Heparin use for blood clots: Study |
None |
| 2012-02-15 |
Mylan responds to current preservative-free Methotrexate Injection shortage |
None |
| 2012-02-15 |
Curcumin prolongs life and enhances activity of fruit flies with AD |
5 |
| 2012-02-15 |
New group of compounds may protect brain cells from inflammation |
None |
| 2012-02-15 |
New vaccine can prevent bacterial infection of orthopaedic implants |
None |
| 2012-02-15 |
Antibiotic prescriptions do not reduce sinus symptoms |
None |
| 2012-02-14 |
Kowa announces data of LIVALO vs. Crestor on pharmacodynamics of warfarin |
None |
| 2012-02-14 |
Abbott's Tacrolimus assay provides consistent medication monitoring for organ transplant patients |
None |
| 2012-02-14 |
Stress protein effectively activates replication of HBV in liver cells |
5 |
| 2012-02-14 |
Karo Bio decides to discontinue development program for eprotirome |
4 |
| 2012-02-14 |
Supply of childhood leukemia drug nearly exhausted |
None |
| 2012-02-14 |
FDA requests a budget of $4.5 billion to protect and promote public health |
None |
| 2012-02-14 |
FDA accepts Gilead's Truvada sNDA and grants Priority Review |
None |
| 2012-02-14 |
Norwegian government introduces legal limits for 20 illegal drugs and medicines |
None |
| 2012-02-14 |
Compound makes imipenem 16 times more effective against antibiotic-resistant K. pneumoniae |
None |
| 2012-02-13 |
Scientists test new 'therapeutic vaccine' against HIV on volunteers |
None |
| 2012-02-13 |
Help combat antibiotic resistance with better patient communication |
None |
| 2012-02-13 |
Tenofovir associated with significant risk of kidney damage and chronic kidney disease |
None |
| 2012-02-13 |
Merck's ZIOPTAN for reducing elevated IOP receives FDA approval |
None |
| 2012-02-13 |
Ocean Nutrition Canada purchases Alicorp fish oil refining plant |
None |
| 2012-02-13 |
Athletes with lumbar disc herniations may benefit from epidural steroid injections |
None |
| 2012-02-13 |
OncoSec to commence OMS ElectroImmunotherapy Phase II trial in MCC |
None |
| 2012-02-13 |
Censorship of public health websites by Russian drug agency an 'assault' on HIV prevention |
None |
| 2012-02-13 |
BIO President issues statement on FDA guidance for biosimilars |
None |
| 2012-02-13 |
Benefits of long-term Kineret therapy in people with NOMID |
None |
| 2012-02-13 |
Organ transplant patients can benefit from cochlear implants |
None |
| 2012-02-13 |
Bexarotene appears to help clear out excess plaque in Alzheimer's |
5 |
| 2012-02-13 |
Pioglitazone can prevent long term effects of maternal obesity on offspring |
None |
| 2012-02-13 |
Molecular secrets behind halofuginone's power |
None |
| 2012-02-13 |
Proposed intellectual property agreement between E.U., India could affect generic drug exports, advocacy groups say |
None |
| 2012-02-13 |
Watson seeks FDA approval to market generic Beyaz |
None |
| 2012-02-13 |
Curcumin may block growth of castrate-resistant prostate tumors |
None |
| 2012-02-12 |
Research team studies effect of anabolic steroids on body fat |
None |
| 2012-02-12 |
FDA lays guidelines for “biosimilar” biotech drugs |
None |
| 2012-02-10 |
Osiris provides update on status of development, commercialization agreement with Genzyme |
None |
| 2012-02-10 |
Vytacera Pharma to develop Sulfanegen for treatment of cyanide poisoning |
None |
| 2012-02-10 |
Prescription medications may affect 17-OHPC metabolism in women |
None |
| 2012-02-10 |
State roundup: Iowa ponders HPV awareness program; Md. workers will see pharmacy plan change; Mass. changes saving money for cities |
None |
| 2012-02-10 |
RI Hospital to study treatment that may prevent post-traumatic OA |
None |
| 2012-02-09 |
Single fibronectin injection can prevent chronic pain development after SCI |
None |
| 2012-02-09 |
SSRIs may minimize risk of Sudden Unexpected Death in Epilepsy |
None |
| 2012-02-09 |
Mylan's generic Doryx ANDA receives final FDA approval |
None |
| 2012-02-09 |
FDA panel votes against Amgen’s Xgeva in prostate cancer |
None |
| 2012-02-09 |
Acid reducing drugs could raise risk of C. diff diarrhea |
None |
| 2012-02-09 |
Combination of anti-obesity drugs and lifestyle advice effective in reducing weight, BMI |
None |
| 2012-02-09 |
New iHeal project aims to detect drug cravings and prevent medication use |
None |
| 2012-02-09 |
Antidepressants make patients feel less satisfied after THR |
None |
| 2012-02-09 |
Stimulants do not increase risk of cardiovascular events in youth with ADHD |
None |
| 2012-02-09 |
Fasting and chemotherapy drugs more effectively treat cancers |
None |
| 2012-02-09 |
Apotex makes payment to Sanofi, Bristol-Myers Squibb to satisfy damages in Plavix patent litigation |
None |
| 2012-02-09 |
Scientists study a botanical formula that kills aggressive prostate cancer tumors |
None |
| 2012-02-09 |
Bisphosphonates may raise risk of atypical femur fracture |
None |
| 2012-02-08 |
Watson settles ORTHO TRI-CYCLEN LO patent litigation with Janssen |
None |
| 2012-02-08 |
RV5 vaccination does not increase risk of intussusception in infants |
None |
| 2012-02-08 |
Guardian blog interviews researcher regarding artemisinin synthesis discovery |
None |
| 2012-02-08 |
APP to launch Meropenem, Cilastatin and Imipenem in the U.S. |
None |
| 2012-02-08 |
Scientists reveal how psychostimulant drugs work to control hyperactivity |
None |
| 2012-02-08 |
GSK launches Medivir's Xerclear for OTC use in Europe |
None |
| 2012-02-08 |
Study determines prevalence of vitamin D deficiency among post menopausal women with DRF |
None |
| 2012-02-08 |
Tips to understand drug-related recall |
None |
| 2012-02-08 |
New immunotherapy combination prolongs survival in dogs with NHL |
None |
| 2012-02-08 |
FDA accepts Genentech's pertuzumab BLA and grants Priority Review |
None |
| 2012-02-08 |
Umbilical cord cleaning with chlorhexidine reduces infant's risk of infection |
None |
| 2012-02-07 |
FGF21 hormone causes significant and rapid bone loss in mice |
None |
| 2012-02-07 |
FDA approves ivermectin lotion for treatment of head lice |
None |
| 2012-02-07 |
Roche’s new breast cancer drug Pertuzumab up for FDA review |
None |
| 2012-02-07 |
Merck applies for approval of its new insomnia drug suvorexant |
None |
| 2012-02-07 |
FDA reviews Amgen’s prostate cancer drug Xgeva |
None |
| 2012-02-07 |
Antiretroviral therapy does not increase severity of psychiatric disorders |
None |
| 2012-02-07 |
Proactive test-and-treat case-detection strategy can combat malaria |
None |
| 2012-02-07 |
New blood-thinning drugs likely to replace Coumadin for patients with non-valvular AF |
1.7 |
| 2012-02-07 |
DMPA intake may increase risk of periodontitis, gingivitis in women |
None |
| 2012-02-07 |
New scoring method helps predict functional outcomes in stroke |
None |
| 2012-02-07 |
EpiCept seeks FDA Fast Track designation for AmiKet to treat CIPN |
None |
| 2012-02-06 |
Mylan acquires two dermatological drugs from Valeant |
None |
| 2012-02-06 |
Watson, Acorda partner to introduce tizanidine hydrochloride capsules |
None |
| 2012-02-06 |
Combination of ICS and LABA appears to reduce severe asthma attacks |
None |
| 2012-02-06 |
Valeant divests generic Benzaclin and Efudex to Mylan |
None |
| 2012-02-06 |
Soligenix reports positive results from preclinical studies of vaccine thermostabilization technology |
None |
| 2012-02-06 |
Sandoz sends Remodulin Paragraph IV Notice Letter to United Therapeutics |
None |
| 2012-02-06 |
Takeda launches EDARBYCLOR in the U.S. for treatment of hypertension |
1 |
| 2012-02-06 |
Clinuvel submits SCENESSE MAA to EMA for treatment of erythropoietic protoporphyria |
None |
| 2012-02-04 |
MSL becomes a key link between pharmaceutical industry and stakeholders |
None |
| 2012-02-04 |
New approach can solve treatment-resistant problem in cancers |
None |
| 2012-02-04 |
UTMB's international vaccine symposium to be held Feb. 7-9 |
None |
| 2012-02-04 |
Combination of Toca 511 and 5-FC may prolong survival in glioblastoma |
1 |
| 2012-02-04 |
Cardinal Health receives TRO to resume controlled medicine shipments from Lakeland |
None |
| 2012-02-04 |
Watson: ANDA for generic Lidoderm remains on track |
None |
| 2012-02-04 |
Mineral and multivitamin supplements can lower risk of colon cancer |
None |
| 2012-02-04 |
New editorial offers clarity on confusing drug and alcohol addiction terminology |
None |
| 2012-02-03 |
Aggrenox not affected by co-administration of omeprazole: Study |
None |
| 2012-02-03 |
Majority of geriatric patients in German rehabilitation hospital have vitamin D deficiency |
None |
| 2012-02-03 |
Pertuzumab plus trastuzumab and docetaxel has advantages over current clinical gold-standard treatment |
None |
| 2012-02-03 |
Strategies to minimize side effects of oxaliplatin in metastatic colon cancer |
4 |
| 2012-02-03 |
Merck Serono enters development agreement with Threshold for hypoxia-targeted drug |
None |
| 2012-02-03 |
FDA intends to grant Priority Review designation for ThromboGenics' ocriplasmin |
None |
| 2012-02-03 |
Thermo Fisher Scientific introduces new handheld narcotics analyzer |
None |
| 2012-02-03 |
Scientists discover new mechanisms by which RNA drugs can control gene activity |
None |
| 2012-02-03 |
EUSA Pharma acquires ASPAREC development and commercialization rights |
None |
| 2012-02-03 |
Merck receives FDA approval for JANUMET XR to treat type 2 diabetes |
None |
| 2012-02-03 |
Websites advertising statins for sale contain poor levels of safety information |
None |
| 2012-02-03 |
Nuvo launches Synera in the U.S. |
None |
| 2012-02-03 |
FDA grants Mylan tentative approval for Atorvastatin Calcium ANDA |
None |
| 2012-02-02 |
Pfizer recalls a million oral contraceptive pills |
None |
| 2012-02-02 |
Mass. bill would mandate docs to check database before prescribing pain meds |
None |
| 2012-02-02 |
Treatment with clot-busting drugs safe for patients with wake-up stroke |
None |
| 2012-02-02 |
Researchers reveal how antipsychotics affect metabolism by SMAD3 activation |
None |
| 2012-02-02 |
Multiple exposures to anesthesia associated with higher rates of ADHD in children |
5 |
| 2012-02-02 |
FDA EMDAC to discuss Arena's lorcaserin NDA resubmission in second quarter |
None |
| 2012-02-02 |
AstraZeneca, Impax enter license agreement to commercialize Zomig in the U.S. |
None |
| 2012-02-02 |
Genentech receives FDA approval for Vismodegib to treat skin cancer |
None |
| 2012-02-01 |
FDA extends Novartis' Gleevec label to three-year treatment in patients with KIT+ GIST after surgery |
None |
| 2012-02-01 |
Counterfeit Drugs - New technology to combat counterfeit |
None |
| 2012-02-01 |
Cystic fibrosis drug gets FDA approval |
5 |
| 2012-02-01 |
GSA's new resources address pain management, labeling changes for acetaminophen |
None |
| 2012-02-01 |
BU scientists create unique material and drug delivery mechanism |
None |
| 2012-02-01 |
General anesthesia may lower recurrence risk in patients with HCC |
None |
| 2012-02-01 |
Continuous wound infusion with local anesthetic reduces pain after hip surgery |
None |
| 2012-02-01 |
NanoViricides files FluCide pre-IND briefing document with the FDA |
None |
| 2012-02-01 |
Novartis' Gleevec receives FDA approval for use in patients with CD117-positive GIST |
None |
| 2012-02-01 |
Crizotinib can treat ROS1-driven tumors |
None |
| 2012-02-01 |
Vertex receives FDA approval for Kalydeco to treat rare form of CF |
None |
| 2012-02-01 |
FDA approves Lannett's supplemental ANDA for Phentermine HCl to treat obesity |
None |
| 2012-02-01 |
Milestone for Starpharma's drug delivery program |
None |